Loading
  • Twitter
  • LinkedIn
  • 中文
  • EN
  • About
    • Our Mission
    • Leadership
  • Technology
    • Our Focus
    • Our Platform
    • Partnering
    • Foundational Publications
  • Pipeline
    • Our Pipeline
    • Therapeutic Area Focus
    • Publications & Presentations
  • Careers
    • Our Values
    • Employee Stories
    • Open Positions
  • Investors & Media
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Analyst Coverage
    • Shareholder Services
  • Contact
  • Menu Menu

About Us

Replacing biologics and peptides with innovative, small molecule drugs.

Structure’s Mission

Biologics and peptides have revolutionized healthcare – offering life-changing, breakthrough medicines to patients in desperate need. These highly innovative large molecules have now set the stage for a new generation of equally transformative orally available small molecule medicines. The global patient need remains immense, and with enhanced pharmaceutical properties, such as improved oral bioavailability, stability, easier logistics and reduced cost, small molecule medicines could address a market worth more than $300 billion annually.

THIS IS EXACTLY WHAT OUR TEAM AT STRUCTURE IS DRIVEN TO ACCOMPLISH.

DRUG DISCOVERY EXPERTISE

Harnessing structure-based drug design, coupled with our advanced computational technologies and world-class expertise, we are committed to converting biologics and peptides into life-changing small molecule medicines for everyone around the world.

Our Team

Global solutions require global expertise. At Structure, we are led by an experienced group of drug hunters and industry leaders from around the world, including scientific experts who are renowned in the field of GPCR-targeted structure-based drug discovery. Our team includes pioneers in solving various G-protein coupled receptor (GPCR) protein structures, providing a strong foundation for tackling even the most difficult drug targets.

Raymond Stevens, Ph.D.

August 16, 2023
Chief Executive Officer
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Ray.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-08-16 10:39:512023-08-16 17:21:45Raymond Stevens, Ph.D.

Mark Bach, M.D., Ph.D.

August 16, 2023
Chief Medical Officer
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Mark.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-08-16 09:50:052023-08-16 17:18:26Mark Bach, M.D., Ph.D.

Xichen Lin, Ph.D.

August 14, 2023
Chief Scientific Officer
General Manager,
Structure Shanghai
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots_xiChen-1.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-08-14 09:51:172023-08-16 17:18:51Xichen Lin, Ph.D.

Yingli Ma, Ph.D.

August 13, 2023
Chief Technology Officer
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots_Yingli-1.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-08-13 08:51:532023-08-16 17:20:18Yingli Ma, Ph.D.

Melita Jung

August 12, 2023
Chief Business Officer
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Melita.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-08-12 09:50:552023-08-22 11:29:24Melita Jung

Jun Yoon

August 11, 2023
Chief Financial Officer
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots_Jun-1.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-08-11 09:51:342023-08-16 17:20:53Jun Yoon

Fang Zhang, Ph.D.

August 10, 2023
Executive Vice President
Head of Biology
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Fang.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-08-10 09:52:112023-08-16 17:21:08Fang Zhang, Ph.D.
Belen Carrillo-Rivas

Belen Carrillo-Rivas, D.Phil.

June 20, 2023
Senior Vice President
Regulatory Affairs
https://structuretx.com/wp-content/uploads/Belen-website.png 600 600 Justin /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Justin2023-06-20 17:00:312023-08-16 17:26:49Belen Carrillo-Rivas, D.Phil.

Lani Ibarra

June 19, 2023
Senior Vice President
Clinical Development Operations
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Lani.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-06-19 09:52:362023-08-16 17:27:04Lani Ibarra

Xinglong Jiang, Ph.D.

June 18, 2023
Senior Vice President
Preclinical Development
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Xing.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-06-18 09:52:592023-08-16 17:33:22Xinglong Jiang, Ph.D.

Hui Lei, Ph.D.

June 17, 2023
Senior Vice President
Chemistry
https://structuretx.com/wp-content/uploads/ShouTi_Headshot_Hui_Lei_02.10.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-06-17 09:53:172023-08-16 17:29:55Hui Lei, Ph.D.

Marc Navre, Ph.D.

June 16, 2023
Senior Vice President
Head of Biology
Structure Basecamp Bio
https://structuretx.com/wp-content/uploads/Marc-Navre.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-06-16 09:53:552023-08-16 17:30:17Marc Navre, Ph.D.

Tony Peng

June 15, 2023
Senior Vice President
Legal
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-Tony-Peng-v3.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-06-15 09:54:132023-08-16 17:30:39Tony Peng

Karen S. Wright

June 12, 2023
Senior Vice President
Finance and Controller
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Karen.png 600 600 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-06-12 09:54:322023-08-16 17:30:58Karen S. Wright

Board of Directors

Ted W. Love, M.D.

July 3, 2023
Former President and Chief Executive Officer,
Global Blood Therapeutics
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Justin /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Justin2023-07-03 17:00:152023-08-02 21:43:50Ted W. Love, M.D.

Eric Dobmeier

January 17, 2023
Chief Executive Officer,
Chinook Therapeutics
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-01-17 17:10:422023-01-17 17:12:21Eric Dobmeier

Joanne Waldstreicher, M.D.

January 3, 2023
Former Chief Medical Officer,
Johnson & Johnson
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2023-01-03 17:00:432023-08-02 21:39:09Joanne Waldstreicher, M.D.

Sharon Tetlow

April 4, 2022
Chair of the Audit Committee
Managing Partner,
Potrero Hill Advisors
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2022-04-04 10:05:552023-02-02 14:36:20Sharon Tetlow

Raymond Stevens, Ph.D.

April 4, 2022
Chief Executive Officer,
Structure Therapeutics
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2022-04-04 10:05:372022-07-25 17:00:10Raymond Stevens, Ph.D.

Ramy Farid, Ph.D.

April 4, 2022
Chief Executive Officer,
Schrödinger
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2022-04-04 10:04:572022-06-27 11:33:44Ramy Farid, Ph.D.

Daniel G. Welch

April 4, 2022
Chairman
Former Chief Executive Officer,
InterMune
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Graham /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Graham2022-04-04 10:04:342023-02-02 14:41:32Daniel G. Welch
Privacy Policy | Terms of Use 2023 Structure Therapeutics
Scroll to top